Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients

NCT01303887

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Ysbyty Gwynedd Bangor, United Kingdom
  • Birmingham Heartlands Birmingham, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
View all 73 locations
View Trial Details
Completed

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

NCT05225584

Conditions
Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

NCT03235544

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Alabama At Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Rocky Mountain Cancer Center-Aurora Aurora, Colorado, United States
  • Asclepes Research Centers Brooksville, Florida, United States
View all 103 locations
View Trial Details
Completed

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

NCT03126019

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +18 more
Locations
  • Arizona Oncology Associates - Biltmore Cancer Center Phoenix, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Synergy Hematology and Oncology Medical Associates Los Angeles, California, United States
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
View all 83 locations
View Trial Details
Completed

An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma

NCT02783300

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 15 locations
View Trial Details
Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions